A Phase 1 interventional study of injecting dexmedetomidine and injecting mixture of bupivacaine fentanyl in Labour Analgesia, sponsored by Minia University Hospital. Not yet recruiting at 1 site in Egypt. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-12.
Sponsored by Minia University Hospital · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To evaluate the efficacy and safety of dexmedetomidine as an adjuvant to bupivacain and fentanyl in spinal Analgesia to decreases pain during normal labour
Effect of adding dexmedetomidine to bupivacain fentanyl mixture in spinal analgesia for normal labour
Minia University Hospital is the lead sponsor of 7 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age of patint is between 18 and 40 years. gestational age of fetus is more than 37 weeks. singleton viable fetus and cephalic presentation. spontaneous labor with cervix dilation more than 5cm.
Exclusion Criteria:
Drug allergy. Blood Disease. Infection at site of injection. patient takes anticoagulants. patient has pre-eclampsia ,cardiac disease ( III-IV) or diabetes mellitus type I prior to the pregnancy patients refuse
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive intrathecaliy hyperbaric bupivacaine 2.5 mg (0.5 mL) combined with dexmedetomidine 2.5 µg and fentanyl 25 µg, diluted to a total volume of 2.5 mL. The solution will be administered as a single spinal injection under aseptic conditions.
Drug: injecting dexmedetomidine
Participants will receive intrathecaliy hyperbaric bupivacaine 2.5 mg (0.5 mL) combined with fentanyl 25 µg, diluted to a total volume of 2.5 mL. The solution will be administered as a single spinal injection under aseptic conditions.
Drug: injecting mixture of bupivacaine fentanyl
injecting dexmedetomidine intrathecally during labour pain
injecting mixture of bupivacaine fentanyl intrathecally
changes in numeric pain intensity score ( NPSI) maximum 10 minimum 0
evaluate the safety and effecacy of dexmetomidine for labour pain by numeric pain intensity score maximum 10 ( sever pain ), minimum 0 ( no pain )
Time frame: baseline
duration of sensory blockade
change in numeric pain intensity score ( NPIS )
Time frame: 5 minutes after injection of analgesic agents till normal delivery done
changes in numeric pain intensity score ( NPIS )
Scores range from 0-10 points, maximum ( 10 ) means sever pain, minimum ( 0 ) means no pain
Time frame: 5 minutes, 10 minutes, 15 minutes, 30 minutes and 45 minintes after injection of analgesic agents
Plan to share: Yes — all collected IPD,
Supporting information: Study protocol
Time frame: december 2025 - december 2026
Access criteria: labour analgesia
Data sharing details ↗ · clinicaltrials.gov
No publications or documents are linked to this record.
Start is estimated for Dec 2025; primary completion for Jan 2026, 0 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Minia University Hospital